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Introduction
Increasingly we are seeing medium or high throughput screens (HTS) used to develop ligand-based models for individual transporters (Diao et al., 2009; Zheng et al., 2009; Diao et al., 2010; Kido et al., 2011; Astorga et al., 2012; Greupink et al., 2012; Dong et al., 2013; Sedykh et al., 2013; Wittwer et al., 2013; Xu et al., 2013; Dong et al., 2014) . One of the significant limitations of this is that the models developed are rarely accessible outside of the research group developing them likely due to the commercial software required. One way to surmount this is the development of models using open source software. We previously showed that such "open models" produce validation statistics that are comparable to commercial tools (Gupta et al., 2010) . As many computational machine learning methods use molecular "function class fingerprints of maximum diameter 6" (FCFP6) and "extended connectivity (ECFP6) fingerprints," we have described their implementation with the Chemistry Development Kit (CDK) (Steinbeck et al., 2003) components (Clark et al., 2014 ). We also recently described how an open source Bayesian algorithm can be used with these descriptors to develop and validate thousands of datasets including those from the ChEMBL database . In response to the shift towards mobile computing, we have developed apps for drug discovery, leveraging years of research in cheminformatics (Williams et al., 2011; Clark et al., 2013; Clark et al., 2014) . A number of mobile apps have been created for sketching and sharing molecules (e.g. MMDS, MolPrime and ODDT (Supplemental Table 1) ). A mobile app that enables a scientist to select a molecule and score it with models (e.g. for various transporters of relevance for drugdrug interactions) is now possible. As a proof of concept we have used transporters modeled previously (Zheng et al., 2009; Diao et al., 2010; Astorga et al., 2012; Dong et al., 2013; Dong et al., 2014) . In the current study we describe validated 
Materials and Methods
Recently we described the development of open source FCFP6 and ECFP6 descriptors and the Bayesian algorithm which enables us to build models with open source tools (Clark et al., 2014; . The CDK codebase has been deposited in the latest version of Github (http://github.com/cdk/cdk: in the 'tools' section, look for class org.openscience.cdk.fingerprint.model.Bayesian). Due to their open nature, future tools can build on them. Previously we published several transporter models and described Bayesian models generated using Discovery Studio (Biovia, San Diego, CA) for (MATE 1, MATE 2K, OCTN2, ASBT and NTCP) (Diao et al., 2009; Diao et al., 2010; Zheng et al., 2010; Astorga et al., 2012; Dong et al., 2013; Dong et al., 2014) .
We have now analyzed several larger published datasets from other groups for MATE1 (Wittwer et al., 2013) and OCT2 (Kido et al., 2011) which we have also used to generate Bayesian models with Discovery Studio to compare the different fingerprints. To illustrate the utility of transporter models built with open ECFP6 descriptors and the Bayesian algorithm, "5-fold cross validation and leave one out" (LOO) cross validation was used. Receiver Operator Curve (ROC) values were produced, where a value of 1 is ideal and a value greater than 0.7 is considered good. Cutoffs for actives and inactives were as previously described (Diao et al., 2009; Diao et al., 2010; Zheng et al., 2010; Kido et al., 2011; Astorga et al., 2012; Dong et al., 2013; Wittwer et al., 2013; Dong et al., 2014) . Open transporter models were developed using open source software (Clark et al., 2014; and loaded into the Mobile Molecular Data Sheet (MMDS (http://molmatinf.com/)) ( Fig 1A-C) and then several MATE models were used to score DX-619, a MATE inhibitor (Imamura et al., 2013) (Fig 1C) . Transporter datasets from ChEMBL (Bento et al., 2014; Papadatos et al., 2014) (Fig 2) were used to illustrate our work to determine a cutoff for activity and automated model building and validation . These models are also openly accessible as part of a set of over 2000 models (http://molsync.com/bayesian2) and can be uploaded into MMDS in order to score molecules of interest.
Results and Discussion
We have described the use of seven datasets representing six transporters of interest (MATE 1, MATE 2K, OCT2, OCTN2, ASBT and NTCP) due to their potential involvement in drug-drug interactions (Diao et al., 2009; Zheng et al., 2009; Diao et al., 2010; Kido et al., 2011; Astorga et al., 2012; Greupink et al., 2012; Dong et al., 2013; Sedykh et al., 2013; Wittwer et al., 2013; Xu et al., 2013; Dong et al., 2014) .
We focused on Bayesian models with ECFP6 and FCFP6 descriptors as these were previously used to develop models that were successfully validated using prospective This article has not been copyedited and formatted. The final version may differ from this version. (Clark et al., 2014; (Clark et al., 2014) . These datasets and open source Bayesian models are also available via http://molsync.com/transporters.
The models with the larger training sets, such as for MATE1 and OCT2, had very comparable ROC values across models. The combination of published NTCP datasets (Dong et al., 2013; Dong et al., 2014) for the first time here produced less desirable models consistently.
We previously suggested hMATE1 may have a complex binding surface, rather than a single binding site (Astorga et al., 2012) . Because datasets have been developed for different substrate probes there is now the potential to build substrate specific models for a single transporter. This may be useful to predict substrate specific drug-drug interactions. As an example we have used the antibiotic molecule DX-619 as a test case which was predicted in MMDS (Fig 1A, B) Fig 1C) . This may suggest that future drug-drug interaction studies could focus on using MPP as the substrate probe rather than ASP. A similar computational model building and sharing approach could be taken for drug metabolizing enzymes, nuclear receptors and ion channels of interest for drugdrug interaction and toxicity prediction (Ekins 2014) . The ChEMBL database has thousands of datasets curated from the literature for important drug targets, including transporters. We recently described, using a novel automated approach, how a cut-off for activity can be selected for such datasets, and models built and validated (Fig 2A,B ) . These models could be uploaded alongside the transporters from the users own, or other published, datasets in order to profile compounds of interest.
The analysis and prediction of a molecule's propensity for drug-drug interactions mediated via transporters or other proteins could be useful to suggest future experiments. As the models can be stored in the mobile app and would not have to communicate over the internet, such calculations would be secure and may be useful for proprietary studies. This suggests an approach to making transporter models accessible to a larger audience of scientists with the potential to transform how models are built and shared with implications for drug discovery.
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